Astellas Ireland Co. Ltd
UkraineAll drugs from this manufacturer
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Dosage form: capsules, extended-release
Active substance Dosage tacrolimus 3 mg ATC: L04AD02
-
The drug is used for the prevention and treatment of liver, kidney, and heart transplant rejection, as well as for the treatment of rejection that is resistant to other immunosuppressive therapies.
Dosage form: solution for injection, concentrate for preparation of intravenous solution
Active substance Dosage tacrolimus 5 mg/ml ATC: L04AD02
-
The drug is used to prevent rejection following liver, kidney, or heart transplantation, as well as to treat organ rejection if it has already begun and is unresponsive to other treatments.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
-
The drug is used to prevent rejection following liver, kidney, or heart transplantation, as well as to treat organ rejection if it has already occurred and is unresponsive to other treatments.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
-
The drug is used to prevent rejection following liver, kidney, or heart transplantation, as well as to treat organ rejection if it has already occurred and is unresponsive to other treatments.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 5 mg ATC: L04AD02